Kaplan‐Meier survival curves showed that patients with high HSPA5 expression had significantly diminished overall survival (OS) compared to those with low expression in adenoid cystic carcinoma (ACC), bladder cancer (BLCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), glioblastoma (GBM), liver hepatocellular carcinoma (LIHC), and uveal melanoma (UVM) (Figure S4, Supporting Information). This evidence concerns the gene HSPA5 and adrenal cortex carcinoma.